Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences

Alzheimer's disease (AD), a neurodegenerative disorder, is a major health concern in the increasingly aged population worldwide. Currently, no clinically effective drug can halt the progression of AD. C.A. Mey is a well-known medicinal plant that contains ginsenosides, gintonin, and other compo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Frontiers in pharmacology 2021-06, Vol.12, p.688490-688490
Hauptverfasser: Li, Jing, Huang, Qingxia, Chen, Jinjin, Qi, Hongyu, Liu, Jiaqi, Chen, Zhaoqiang, Zhao, Daqing, Wang, Zeyu, Li, Xiangyan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Alzheimer's disease (AD), a neurodegenerative disorder, is a major health concern in the increasingly aged population worldwide. Currently, no clinically effective drug can halt the progression of AD. C.A. Mey is a well-known medicinal plant that contains ginsenosides, gintonin, and other components and has neuroprotective effects against a series of pathological cascades in AD, including beta-amyloid formation, neuroinflammation, oxidative stress, and mitochondrial dysfunction. In this review, we summarize the effects and mechanisms of these major components and formulas containing in neuronal cells and animal models. Moreover, clinical findings regarding the prevention and treatment of AD with or its formulas are discussed. This review can provide new insights into the possible use of ginseng in the prevention and treatment of AD.
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2021.688490